December 2021: Association of ECT With Risks of All-Cause Mortality and Suicide in Older Medicare Patients - American Journal of Psychiatry Audio | Lyssna här

In this month’s AJP Audio, Dr. Samuel Wilkinson (Yale University, Associate Director of the Yale Depression Research Program) discusses a study looking at the association of electro-convulsive therapy or ECT on all-cause mortality and suicide in Medicare patients with mood and bipolar disorders. Following that, Dr. Ned Kalin, Editor-in-Chief of the Journal discusses the December issue of AJP.

Wilkinson interview: Effects of ECT on older patients with mood disorders [00:50]
A brief history of ECT [01:20]
A troubled history [02:00]
A backlash against ECT [02:24]
Improved techniques and practices [03:32]
Limitations of past research into ECT [04:20]
Strength of the study [05:33]
How patients were matched [05:59]
Limitations of the present study [07:17]
Treatment of patients going forward [08:18]
Difficulties in administering and accessing ECT [09:49]
Next steps in research into ECT and patients with elevated suicide risk [11:14]
All-cause mortality and ECT [11:57]
Kalin interview: The December issue of AJP [13:02]
Major depressive and bipolar disorders [13:13]
“Neuromodulation Strategies for the Treatment of Depression” [13:42]
“Association of ECT With Risks of All-Cause Mortality and Suicide in Older Medicare Patients” [14:19]
“Efficacy and Safety of Lumateperone for Major Depressive Episodes Associated with Bipolar I or Bipolar II Disorder: A Phase 3 Randomized Placebo-Controlled Trial” [15:29]
Ostacher editorial [17:44]
“Association Between Systemic Inflammation and Individual Symptoms of Depression: A Pooled Analysis of 15 Population-Based Cohort Studies” [18:18]
Pariante editorial [20:42]
“Coordinate-Based Network Mapping of Brain Structure in Major Depressive Disorder in Younger and Older Adults: A Systematic Review and Meta-Analysis” [21:23]
Putting the issue into context [23:00]

Be sure to let your colleagues know about the podcast, and please rate and review it on Apple Podcasts, Google Podcasts, Stitcher, Spotify, or wherever you listen to it.